Decreased function of fatty acid desaturase 1 is associated with placental foetal vascular malperfusion and highlights the key role of the maternal–foetal interface
Abstract
Background Placental foetal vascular malperfusion (PFVM) is a chronic disorder characterised by impaired blood flow and abnormal vascular development, inducing adverse neonatal outcomes. Long chain polyunsaturated fatty acids (LC-PUFAs) play a crucial role in placenta health. We aimed to explore the role of genetic variation in LC-PUFA metabolism in PFVM risk as well as underlying mechanisms. Methods Associations were examined between two functional polymorphisms (rs174538 and rs174556) of the fatty acid desaturase 1 ( FADS1 ) gene encoding the rate-limiting enzyme for LC-PUFA metabolism and PFVM among pregnant women (n = 646). Placental transcriptomes were correlated with PFVM and FADS1 genotypes. Various assays were performed in human umbilical vein endothelial cells and trophoblasts with FADS1 inhibitor and LC-PUFA interventions to characterise their function changes. Findings Low-function alleles of both polymorphisms were significantly associated with increased PFVM risk and decreased placental FADS1 transcription level. In placenta tissue, lower FADS1 expression is also associated with PFVM. PFVM-associated genes are enriched to pathways related to immune responses, apoptosis, and angiogenesis, which overlap with the genes and pathways associated with the risk alleles and demonstrate a cell-type enrichment to endothelial cells. In vitro, FADS1 inhibition impairs multiple functions of and interactions between endothelial and trophoblast cells. These impairments are reversed by LC-PUFA supplementation. Interpretation These findings highlight the impact of maternal LC-PUFA homoeostasis in placenta health and suggest that maternal FADS1 variants can potentially be an early diagnostic marker for PFVM. Our data supports PUFA metabolism as a precision therapeutic or preventive target to reduce placental dysfunction risk. Funding NIH, Wayne State University and Michigan State University.
// Source
Authors: Zhenjie Liu, Ze Long, Stephanie Nartey, Tao Li, Shahrazad T. Saab, Ty Partridge, Carolyn M. Salafia, Zheyun Peng, Yang Jiang, Tengfei Ma, Douglas Ruden, Nigel Paneth, Jean M. Kerver, Raina Nakova Fichorova, Wanqing Liu
Institutions: Brigham and Women's Hospital, Wayne State University, Case Western Reserve University, Michigan State University, Second Xiangya Hospital of Central South University, University Hospitals of Cleveland, Henry Ford Health, The Barbara Ann Karmanos Cancer Institute, University Hospitals Cleveland Medical Center, Ball State University, Eugene Applebaum College of Pharmacy and Health Sciences, Great Lakes Environmental Center, Northwestern Michigan College